Beneficial interaction of thymoquinone and sodium valproate in experimental models of epilepsy: Reduction in hepatotoxicity of valproate

Scientia Pharmaceutica

Volumn 74, Issue 4, 2006, Pages 159-173

  Raza, Muhamma ^a   Alghasham, Abdullah A ^a   Alorainy, Mohammad S ^a   El Hadiyah, Tarig M ^b  

^a QASSIM UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Hepatoprotection; Maximal electroshock convulsions; Potentiation; Thymoquinone; Valproate

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; DRINKING WATER; GLUTATHIONE; PENTETRAZOLE; THIOL DERIVATIVE; THYMOQUINONE; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; ELECTRIC SHOCK; EPILEPSY; EXPERIMENTAL STUDY; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN;

EID: 33846388939     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.2006.74.159     Document Type: Article

References (39)

1. Hashim, F.M. and El-Kiey, M.A. Nigella sativa seeds of Egypt. J. Pharm. Sci. UAR, 1962; 3, 121-133.
2. AbouBasha, L.I., Rashed, M.S. and Aboua-Enein,Y. TLC assay of thymoquinone in black seed oil (Nigella sativa) and identification of dithymoquinone and thymol. J. Liq. Chromatogr. 1995;18, 105-115.
3. Canonica, L., Jomoni, G., Scolastico and Bonati, A. The pharmacologically active principle in Nigella sativa. Gazz. Chem. Ital., 1963; 93, 1404-1407.
4. El-Dakhakhny, M. Studies on the chemical constitution of Egyptian Nigella sative L. Seeds. Pharmazie, 1963; 30, 109-111.
5. Sayed, M. D. Traditional medicine in health care. J. Ethnopharmacol., 1980; 2, 19-22.
6. Houghton PI, Zarka R, De las Heras B, Hoult RS. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica, 1995; 61, 33-36.
7. Abdel-Fattah, A.M., Matsumoto, K. and Watanabe, H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur. J. Pharmacol. 2000; 14, 400,89-97.
8. El Tahir, K.E.H. and Ageel, A.M. Effect of the volatile oil of (Nigella sativa) on the arterial blood pressure and heart rate of the guinea pig. Saudi Pharm. J., 1994; 2, 163-168.
9. Chakravarty, N. Inhibition of histamine release from mast cells by Nigellone. Ann. Allergy, 1993; 70, 237-242.
10. Mutabagani, A. and El-Mahdy, S.A.M. A study of the anti-inflammatory activity of Nigella sativa L. and thymoquinone in rats. Saudi Pharm. J., 1997; 5, 110-113.
11. Kruk, I., Michalsks, T., Lichszteld, K., Kladna, A. and Aboul-Enein, H.Y. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere, 2000; 41, 1059-1064.
12. El-Daly, E.S. Protective effect of cysteine and vitamine E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J. Pharm. Belg., 1998; 53, 87-93.
13. Al-Shabanah, O.A., Badary, O.A., Nagi, M.N., Al-Gharably, N.M., Al-Rikabi, A.C. and Al-Bekairi, A.M. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumour activity. J. Exp. Clin. Cancer. Res. 1998; 17, 193-198.
14. Badary, O.A, Nagi, M.N., Al-Shabanah, O.A., Al-Sawaf, H.A., Al-Sohaibani, M.O. and Al-Bekairi, A.M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its anticancer activity. Canadian J Physiol Pharmacol., 1997; 75: 1356-1361.
15. Al-Gharably, N., Badary, O., Nagi, M., Al-Shabanah, O., Al-Sawaf, H., Al-Rikabi, A. and Al-Bekairi, A. Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice. Res. Commun. Pharmacol Toxicol. 1997; 2, 41-50.
16. Badary, O., Al-Shabanah, O., Nagi, M., Al-Rikabi, A. and Elmazar, M. Inhibition of benzo (a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone. Eur. J. Cancer Prev. 1999; 8, 435-440.
17. Nagi, M., Alam, K., Badary, O., Al-Shabanah, O., Al-Sawaf, H., and Al-Bekairi, A. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem. Mol. Biol. Int., 1999; 47, 153-159.
18. Ilhan A, Gurel A, Armutcu F, Kamisli S, Iraz M. Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazole-induced kindling in mice. Neuropharmacology. 2005; S;49(4):456-64.
19. Hosseinzadeh H, Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine. 2004; 11(1):56-64.
20. Hosseinzadeh H, Parvardeh S, Nassiri-Asl M, Mansouri MT. Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit. 2005; 11(4): BR106-110.
21. th ed. Raven press, Ltd., New York, 1995; pp. 99-122.
22. De Deyn, P.P. and Macdonald, R.L. Effects of antiepileptic drugs on GABA responses and on reduction of GABA responses by PTZ and DMCM on mouse neurons in cell culture. Epilepsia, 1989; 30, 17-25.
23. Dhariwal M.A.H; Raza, M; Ageel, A.M.; Al-Haider A.A. A study of the antinociceptive activity of sodium valproate in mice. Pharmacol Commun. 1996; 7: 189-198.
24. Abulaban, F.S; Dhariwal, M.A.H.; Al-Bekairi, A.M. and Raza, M. Antinociceptive activity of sodium valproate in mice after chronic treatment. Gen. Pharmacol. 1997; 29, 463-467.
25. Kruse, H.J. and Kuch, H. Etifoxine: evaluation of its anticonvulsant profile in comparison with sodium valproate, phenytoin and clobazam. Arzneimittel forschung, (Drug Research), 1985; 35, 133-135.
26. Löscher, W. and Nau, H. Valproic acid: Metabolic concentrations in plasma and brain, anticonvulsant activity and effects on GABA metabolism during subacute treatment in mice. Archives Internationales de Pharmacodynamie et de Therapie., 1982; 257, 20-31.
27. Raza, M., Al-Bekairi, M., Ageel, A.M. and Qureshi, S. Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: Time dependence of peroxidative injury. Pharmacol Res., 1997; 35, 153-157.
28. Raza, M., Al-Shabanah OA; Al-Bekairi, AM. and Qureshi, S. Pharmacological changes in mouse liver and kidney during prolonged valproate administration. Int. J. Tissue Reaction, 2000; XXII, 15-22.
29. Ohkawa, H., Ohishi, N., and Yagi, K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal. Biochem., 1979; 95, 351-358.
30. Sedlak, J., and Lindsay, R.H. Estimation of total protein bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Analyt Biochem, 1968; 25, 192-195.
31. Löscher, W., Wahnschaffe, U., Honack, D., Wiltfoht, W. and Nau, H. Effect of valproic acid and E-2-en-valproate on functional and morphological parameters of rat liver; I. Biochemical histopathological and pharmacokinetic studies. Epilepsy Res., 1992; 13, 187-198.
32. Elmazar, M.M.A., Said, S.A., Salim, H.A. and Ghoneim, H.A. Evaluation of hepatotoxicity in rats of four synthetic valproic acid derivatives with potential anticonvulsant activity and low teratogenecity. Saudi Pharm. J., 1997; 5, 162-169.
33. Dreifuss, F.E., Santilli, N., Langer, D.H., Sweeney, K.P., Moline, K.A. and Manander, K.B. Valproic acid hepatic fatalities: a retrospective review. Neurology, 1987; 37, 379-385.
34. Rittle, A.E., Rettewmeier, A.W., Howard, W.N. and Baillie, T.A. Cytochrome P-450 catalysed formation of VPA, a toxic metabolite of valproic acid. Science, 1987; 235, 890-893.
35. Thurston, J.H. and Hauhart, R.E. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme: a metabolism by cotreatment with pentothenate and carnitine in developing mice: possible clinical significance. Pediatr. Res. 1992; 31 (4 pt. 1), 419-423.
36. Brady, J., Xiao, F., Wang, M., Li, Y., Ning, S., Gapac, J., and Yang, C. Effects of disulfiram on hepatic P450 IIEI other microsomal enzymes and hepatotoxicity in rats. Toxicol. Appl. Pharmacol., 1991; 108, 366-374.
37. Min, K., Terano, Y., Onosaka, S., and Tanaka, K. Induction of metallothionine synthesis by nenadione or carbon tetrachloride is independent of free radical production. Toxicol. Appl. Pharmacol., 1992; 113, 74-79.
38. Daba M., and Abdl-Rahman M. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett., 1998; 95, 23-29.
39. Mansour, M. Protective effect of thymoquinone and desferrioxamine against carbon tetrachloride induced hepatotoxicity in normal mice. Life Sci., 2000; 66, 2583-2591.